John L. Brottem - Nov 15, 2021 Form 4 Insider Report for Outset Medical, Inc. (OM)

Signature
John L Brottem
Stock symbol
OM
Transactions as of
Nov 15, 2021
Transactions value $
-$207,278
Form type
4
Date filed
11/16/2021, 03:18 PM
Previous filing
Oct 19, 2021
Next filing
Dec 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Options Exercise $33.2K +3.5K +23.26% $9.48 18.5K Nov 15, 2021 Direct
transaction OM Common Stock Sale -$180K -3.5K -18.87% $51.55 15K Nov 15, 2021 Direct F1, F2
transaction OM Common Stock Options Exercise $13.7K +1.45K +9.6% $9.48 16.5K Nov 15, 2021 Direct
transaction OM Common Stock Sale -$73.7K -1.45K -8.76% $51.03 15K Nov 15, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.45K -2.38% $0.00 59.2K Nov 15, 2021 Common Stock 1.45K $9.48 Direct F3
transaction OM Performance Options (right to buy) Options Exercise $0 -3.5K -20.27% $0.00 13.8K Nov 15, 2021 Common Stock 3.5K $9.48 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020.
F2 The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $51.00-$51.99 - 3,000 shares; $52.00-$52.99 - 500 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.
F4 This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event.